Pharmaceutical formulations of gpr119 agonists and uses thereof

An oral pharmaceutical composition comprising a compound of Formula I or a pharmaceutically acceptable salt thereof:

• wherein
• each R is independently selected from H, halogen, substituted or unsubstituted C1-4 alkyl, and substituted or unsubstituted C1-4 alkoxy;
• A is selected from H, substituted or unsubstituted C1-4 alkyl, substituted or unsubstituted phenyl, substituted or unsubstituted (C1-4 alkyl)phenyl, substituted or unsubstituted 5-6 membered heteroaryl containing one or more heteroatoms selected from N, O, and S, substituted or unsubstituted heterocyclyl containing one or more heteroatom selected from N, O, and S, and substituted or unsubstituted C1-4 alkoxycarbonyl;
• wherein the substituents are selected from halogen, substituted or unsubstituted C1-4 alkyl, and substituted or unsubstituted C1-4 alkoxy;
• n is 0, 1, 2, or 3;
• and
• * denotes a stereocenter;
• and one or more pharmaceutically acceptable excipients,
• wherein the compound of Formula I has a particle size D90 of less than about 200 μm.